Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Same medication, different price by city. Why and what it means for budgeting.
Every few months you hear that Ozempic is out of stock. Here's why the supply is so tight — and what alternatives are available.
What the Drugs Controller General of India has actually approved — and for which conditions.
The legal framework that makes your remote doctor consult valid. The short version, and what it requires from us.
Online sellers and grey-market sources have flooded India with counterfeit semaglutide. Here's how to spot it.
Tirzepatide doesn't just activate GLP-1 — it also activates GIP. Here's why that combination beats either alone.
It's not a routine question. There's a specific reason it comes up before every GLP-1 prescription.
Short answer: no. Longer answer: your body adapts to weight loss, not to the drug.
Ozempic. Rybelsus. Wegovy. Mounjaro. Saxenda. Trulicity. What each is and which conditions they're approved for.
Oral semaglutide exists. It's not as effective as the injectable version, but for the right patient it's the right tool.
Once you've reached your weight goal, you don't stop the medication — you shift to maintenance. Here's what that looks like.
Plateaus on GLP-1 are normal, not failure. Here's why they happen and what to actually do about them.
